Brief: Provectus Biopharmaceuticals Establishes Research Collaboration With University Of Tennessee College Of Veterinary Medicine
28/06/2023 12:42
June 28 (Reuters) - Provectus Biopharmaceuticals Inc
PVCT.PK :
* PROVECTUS BIOPHARMACEUTICALS ESTABLISHES RESEARCH
COLLABORATION
WITH UNIVERSITY OF TENNESSEE COLLEGE OF VETERINARY MEDICINE TO
INVESTIGATE PHARMACEUTICAL-GRADE SMALL MOLECULE IMMUNOTHERAPY
ROSE BENGAL SODIUM FOR CANINE SOFT TISSUE SARCOMAS
Source text for Eikon: ID:nGNX8H21c5
Further company coverage: PVCT.PK
((reuters.briefs@thomsonreuters.com;))
Recent news on Provectus Biopharmaceuticals
See all newsBrief: Provectus Biopharmaceuticals Reports Oral Pv-10 Anti-Tumor Activity In Preclinical Bladder Cancer Study
Brief: Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10
RCS - VisiRose - VisiRose Introduces Therapy for Eye Infections
RCS - FINOS - FINOS Welcomes Seven Financial Leaders
Brief: Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting